<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04211350</url>
  </required_header>
  <id_info>
    <org_study_id>EU-2018-001</org_study_id>
    <secondary_id>2018-A02141-54</secondary_id>
    <secondary_id>ISRCTN16170657</secondary_id>
    <nct_id>NCT04211350</nct_id>
  </id_info>
  <brief_title>SLEEP ON Your SIDE (SOS) Study</brief_title>
  <acronym>SOS</acronym>
  <official_title>A Multi-center, Prospective, Randomized Crossover Study With the NightBalance SPT Compared to Positive Airway Pressure (PAP) for the Treatment of Positional Obstructive Sleep Apnea (POSA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Philips Clinical &amp; Medical Affairs Global</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Philips Clinical &amp; Medical Affairs Global</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of the NightBalance Sleep Position Trainer (SPT) to Positive Airway Pressure (PAP)&#xD;
      for the Treatment of Positional Obstructive Sleep Apnea (POSA). Primary Objective: Efficacy&#xD;
      and Adherence of the SPT over 3 months of use compared to PAP for the treatment of POSA. The&#xD;
      study is run from centers in France, the UK and Germany.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants are randomly allocated to receive one of two treatments, either Automatic&#xD;
      Positive Airway Pressure (APAP) or NightBalance Sleep Position Therapy for a three month&#xD;
      period. Participants are sent home with instructions to use that device nightly at home for&#xD;
      three months. After three months of using the first device, they return to the doctor for&#xD;
      assessment of the efficacy of the device using a sleep test and the compliance read from the&#xD;
      device. Upon conclusion of the first three month treatment period, patients receive the&#xD;
      alternative treatment for a further three months. At the end of the second three month&#xD;
      period, participants return to their doctor again to assess the efficacy of the last device&#xD;
      and read the compliance. Before any treatment and after each treatment, patients undergo a&#xD;
      sleep test and complete some questionnaires. During each treatment period, patients complete&#xD;
      a healthcare utilization diary and report any problems.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 4, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of Apnea-Hypopnea Index (AHI)</measure>
    <time_frame>Baseline,3 months and 6 months</time_frame>
    <description>Efficacy will be measured as Change of Apnea-Hypopnea Index (AHI) from baseline to 3 months and from 3 months to 6 months (NightBalance SPT non-inferior to PAP)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Difference of the total hours medical device use between each treatment arm</measure>
    <time_frame>3 months and 6 months</time_frame>
    <description>Adherence will be measured as the difference between the total hours medical device use from baseline to 3 months and from 3 months to 6 months (NightBalance SPT superior to PAP)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Daytime Sleepiness</measure>
    <time_frame>Baseline,3 months and 6 months</time_frame>
    <description>Daytime sleepiness is measured using Epworth Sleepiness Scale (ESS). Epworth Sleepiness Scale (ESS), has a minimum value 0, maximum value 24 with higher values indicate worsening daytime sleepiness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of sleepiness on activities of daily living</measure>
    <time_frame>Baseline,3 months and 6 months</time_frame>
    <description>Impact of sleepiness on activities of daily living is measured using Functional Outcomes of Sleep Questionnaire (FOSQ). The FOSQ is a sleep related quality of life is measured across five dimensions; activity level, vigilance, intimacy and sexual relationships, general productivity, social outcome. Each rate the difficulty of performing a given activity on a 4-point scale, min value 0, max value 4. Low scores indicate no difficulty, higher scores extreme difficulty.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health related quality of life</measure>
    <time_frame>Baseline,3 months and 6 months</time_frame>
    <description>Health related quality of life is measured using EQ-5D at baseline and at the end of each 3 month treatment arm. Health status is measured in terms of five dimensions (5D); mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels: no problems, slight problems, moderate problems, severe problems, unable to/extreme problems. Responses are coded as single-digit numbers. The digits for the five dimensions can be combined in a 5-digit code that describes the respondent's health state with lower scores indicting worsening health status and higher values improved health status.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>Baseline,3 months and 6 months</time_frame>
    <description>Fatigue is measured using Pichot Fatigue Scale at baseline and at the end of each 3 month treatment arm. The Pichot Fatigue Scale is an 8 question survey in which is answered 0 to 4 with a maximum score of 32. A score above 22 reveals excessive fatigue, patients may suffer from inefficient sleep.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life utilizing SF-36</measure>
    <time_frame>Baseline,3 months and 6 months</time_frame>
    <description>Quality of life is measured using SF-36 at baseline and at the end of each 3 month treatment arm. The 36-Item Short Form Health Survey (SF-36) is an indicator of overall health status. It has the following sections: Vitality, Physical functioning, Bodily pain, General health perceptions, Physical role functioning, Emotional role functioning, Social role functioning, Mental health.&#xD;
The SF-36 has eight scaled scores; the scores are weighted sums of the questions in each section. Scores range from 0 - 100. The lower scores mean more disability, and higher scores mean less disability.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Disease Alleviation</measure>
    <time_frame>3 months and 6 months</time_frame>
    <description>Mean Disease Alleviation is calculated using the AHI and adherence data at the end of each 3-month treatment arm 8. Adverse events are recorded at the end of each 3-month treatment arm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Economics and Resource Utilization</measure>
    <time_frame>3 months and 6 months</time_frame>
    <description>Health Economics and Resource Utilization are assessed using healthcare utilization diary which is completed by patients during each 3-month treatment arm.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>NightBalance Sleep Position Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>NightBalance Sleep Position Trainer (SPT) avoids POSA patients from sleeping on their back by delivering a vibrational stimulus, via a small device which is worn in a chest strap during sleep, each time the patient rolls to their back. This prompts the patient to roll over onto their side.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Positive Airway Pressure (APAP)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Automatic Positive Airway Pressure (APAP) is a pump that provides a positive flow of air to keep the airway open.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NightBalance Sleep Position Trainer (SPT)</intervention_name>
    <description>NightBalance Sleep Position Trainer (SPT) avoids POSA patients from sleeping on their back by delivering a vibrational stimulus, via a small device which is worn in a chest strap during sleep, each time the patient rolls to their back. This prompts the patient to roll over onto their side.</description>
    <arm_group_label>NightBalance Sleep Position Therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Automatic Positive Airway Pressure (APAP)</intervention_name>
    <description>Automatic Positive Airway Pressure (APAP) is a pump that provides a positive flow of air to keep the airway open.</description>
    <arm_group_label>Positive Airway Pressure (APAP)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subject is adult&#xD;
&#xD;
          2. Either: Treatment naïve, or PAP non-complier (defined as current AAP user with &lt;3&#xD;
             hours per night in the last 3 months per compliance download), and willing to use the&#xD;
             APAP device per protocol&#xD;
&#xD;
          3. Diagnosis of POSA meeting all the following criteria per control PSG within 6 months&#xD;
             of screening: AHI of &gt;15 during PSG with symptoms of sleepiness per Investigator&#xD;
             discretion, or AHI of &gt;15 during respiratory polygraphy with comorbidities (e.g.&#xD;
             atrial fibrillation, resistant hypertension, etc.)&#xD;
&#xD;
          4. Supine AHI at least twice the lateral AHI&#xD;
&#xD;
          5. Lateral AHI &lt;10&#xD;
&#xD;
          6. Supine time &gt;30% and &lt;70%&#xD;
&#xD;
          7. Understands the study protocol and is willing and able to comply with study&#xD;
             requirements and sign informed consent. APAP non-compliant subjects must be willing to&#xD;
             use their APAP device per protocol.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Prior or current therapy or treatment for OSA (for Treatment naïve group); Greater&#xD;
             than an average of 3 hours per night of APAP use (in the APAP non-complier group)&#xD;
&#xD;
          2. A female of child-bearing potential that is pregnant or intends to become pregnant&#xD;
&#xD;
          3. Any unstable or severe medical condition of any organ system that at the discretion of&#xD;
             the site Principal Investigator (PI) might affect the patient's participation in the&#xD;
             study or generalization of treatment results&#xD;
&#xD;
          4. Taking medication that at the discretion of the site Principal Investigator (PI) might&#xD;
             affect the patient's participation in the study or generalization of treatment results&#xD;
&#xD;
          5. Oxygen use&#xD;
&#xD;
          6. The presence of any other sleep disorder (central sleep apnea (CSA &gt;5), periodic limb&#xD;
             movement disorder (PLMAI &gt;15), clinical diagnosis of insomnia or narcolepsy)&#xD;
&#xD;
          7. Excessive alcohol consumption (&gt;21 drinks/week)&#xD;
&#xD;
          8. The use of any illegal drug(s), per subject report&#xD;
&#xD;
          9. Night or rotating shift work&#xD;
&#xD;
         10. Severe claustrophobia&#xD;
&#xD;
         11. Shoulder, neck, or back complaints that restrict sleeping position&#xD;
&#xD;
         12. Subject requires use of more than 2 pillows under the head while sleeping or sleeps in&#xD;
             a bed/chair with raised upper body position&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kristine Hautekiet</last_name>
    <phone>+33637009359</phone>
    <email>kristine.hautekiet@philips.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stella Marincheva</last_name>
    <phone>+31640345957</phone>
    <email>stella.marincheva@philips.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Angers</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Frederic Gagnadoux</last_name>
      <email>frederic.gagnadoux@univ-angers.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Grenoble Alpes</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Louis Pepin</last_name>
      <phone>+33476768474</phone>
      <email>jpepin@chu-grenoble.fr</email>
    </contact>
    <contact_backup>
      <last_name>Corinne Loiodice</last_name>
      <phone>+33476768474</phone>
      <email>cloiodice@chu-grenoble.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Bordeaux</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierre Philip</last_name>
      <email>pierre.philip@u-bordeaux.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Bichat - Claude-Bernard</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marie Pia D'Ortho</last_name>
      <email>marie-pia.dortho@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Universitaire Pitié - Salpêtrière (UPMC)</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Valerie Attali</last_name>
      <email>valerie.attali@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Foch, Suresnes</name>
      <address>
        <city>Suresnes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marc Blumen</last_name>
      <email>marc.blumen@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zentrum für Schlafmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ralf Warmuth</last_name>
      <email>ralf@warmuth-online.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Rechts der Isar</name>
      <address>
        <city>München</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Clemens Heiser</last_name>
      <email>hno@heiser-online.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Schlafmedizinisches Zentrum Regensburg</name>
      <address>
        <city>Regensburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Arzt</last_name>
      <email>Michael.Arzt@klinik.uni-regensburg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. Holger Hein</name>
      <address>
        <city>Reinbek</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Holger Hein</last_name>
      <email>hh@dr-holger-hein.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helios Kliniken</name>
      <address>
        <city>Schwerin</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andre Barleben</last_name>
      <email>andre.barleben@helios-gesundheit.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Bethanien Solingen</name>
      <address>
        <city>Solingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Winfried Randerath</last_name>
      <email>Randerath@klinik-bethanien.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Papworth Hospital</name>
      <address>
        <city>Cambridge</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tim Quinnell</last_name>
      <email>Tim.quinnell@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal infirmary of Edinburgh</name>
      <address>
        <city>Edinburgh</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Renata Riha</last_name>
      <email>rlriha@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Prince Philip Hospital</name>
      <address>
        <city>Llanelli</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Keir Lewis</last_name>
      <email>keir_lewis@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Guy's and St Thomas' NHS Foundation Trust (GSTT)</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Panagis Drakatos</last_name>
      <email>Panagis.Drakatos@gstt.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Preston Hospital</name>
      <address>
        <city>Preston</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Himanshu Singh</last_name>
      <email>Himanshu.Singh@lthtr.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>North Tyneside General Hospital</name>
      <address>
        <city>Tyneside</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laura MacKay</last_name>
      <email>Laura.MacKay@northumbria-healthcare.nhs.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>December 23, 2019</study_first_submitted>
  <study_first_submitted_qc>December 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 26, 2019</study_first_posted>
  <last_update_submitted>April 27, 2021</last_update_submitted>
  <last_update_submitted_qc>April 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Positional Obstructive Sleep Apnea</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

